Medical Technologies Co history

Realizing the need for a comprehensive change in the way the company conducted its business, management decided to change its name in 1991 to Palomar Medical Technologies, Inc. to portray a more sophisticated and medically-oriented operation.

In 1995 Palomar Medical Technologies implemented a far-reaching and comprehensive reorganization strategy to carry them into the next century.

Revenues for 1996 totaled $70 million, a phenomenal increase of 220 percent over the previous year's figure of $21 million.

In March 1997, Palomar Medical Technologies received the stamp of approval from the United States Food and Drug Administration to market and sell its Epilaser system for removing body hair.

In 2010, taking advantage of these capabilities and with a willingness to commit to society, Ventura Medical Technologies was created.

2013: ANR and MPJ Healthcare formed NeuroHabilitation Corporation, which signed a Collaborative Research and Development Agreement (CRADA) with the US Department of Defense.

2014: Helius Medical Technologies acquired NeuroHabilitation in a reverse merger and became a publicly traded company on the Canadian Securities Exchange.

2016: Helius Medical Technologies was listed on the Toronto Stock Exchange (TSX).

2017: Helius completed a multi-site, double-blind, randomized, sham-controlled registrational clinical trial investigating the safety and effectiveness of the Portable Neuromodulation Stimulator (PoNS™) in subjects with a chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI)

2018: Helius Medical Technologies was listed on NASDAQ